VC
Vikrant Chanana
About Vikrant Chanana
Data last updated:
Vikrant Chanana has 11 years in corporate governance. Holds Director role. Currently with 2 companies, including Saach Pharmaceuticals Private Limited and Medquits Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Saach Pharmaceuticals Private Limited at ₹3.39 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 02 Jul 2015 | 2015 | ₹3.39 Cr (FY 2024) | Active | |
| Director | 24 Oct 2024 | 2024 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vikrant Chanana
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vikrant Chanana
Vikrant Chanana has 11 years in corporate governance. Holds Director role. Currently with 2 companies, including Saach Pharmaceuticals Private Limited and Medquits Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Saach Pharmaceuticals Private Limited at ₹3.39 Cr (FY 2024).
Vikrant Chanana is associated with 2 companies as Director, including Saach Pharmaceuticals Private Limited (₹3.39 Cr), Medquits Pharmaceuticals Private Limited.
Vikrant Chanana has expertise in General Business.
Vikrant Chanana has 11 years in corporate governance.
By reported revenue, the largest current company of Vikrant Chanana is Saach Pharmaceuticals Private Limited, with revenue of ₹3.39 Cr (FY 2024).
Vikrant Chanana currently holds positions at 2 companies: Saach Pharmaceuticals Private Limited (₹3.39 Cr), Medquits Pharmaceuticals Private Limited.